SCHEMBL13890805

SCHEMBL13890805

CC(C)C(=O)c1ccnc(OCC(F)(F)F)c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ EPHX2 P34913 4/20 0.52
▸ L3MBTL1 Q9Y468 1/20 0.44
▸ MAPT P10636 4/20 0.43
▸ GSK3B P49841 2/20 0.43
▸ JMJD6 Q6NYC1 1/20 0.41
▸ KDM4E B2RXH2 1/20 0.38
▸ DBH P09172 1/20 0.38
▸ GAA P10253 1/20 0.38
▸ RECQL P46063 1/20 0.38
▸ GABRA5 P31644 1/20 0.37
▸ POLB P06746 1/20 0.36
▸ MAPK1 P28482 1/20 0.36
▸ CYP2C9 P11712 2/20 0.36
▸ CYP2C19 P33261 2/20 0.36
▸ CYP17A1 P05093 1/20 0.36
▸ HCRTR1 O43613 1/20 0.35
▸ HCRTR2 O43614 1/20 0.35
▸ CYP2J2 P51589 1/20 0.35
▸ CACNA1G O43497 1/20 0.35
▸ CACNA1H O95180 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31191107 0.87 EPHX2 (0.53) EPHX2L3MBTL1MAPTGSK3BJMJD6
SCHEMBL30403546 0.84 EPHX2 (0.52) EPHX2L3MBTL1MAPTGSK3BJMJD6
SCHEMBL2713663 0.84 EPHX2 (0.52) EPHX2L3MBTL1MAPTGSK3BJMJD6
SCHEMBL796410 0.82 L3MBTL1 (0.60) EPHX2L3MBTL1MAPTJMJD6KDM4E
SCHEMBL27913659 0.81 EPHX2 (0.50) EPHX2L3MBTL1MAPTGSK3BJMJD6
SCHEMBL13875980 0.81 EPHX2 (0.50) EPHX2L3MBTL1MAPTGSK3BJMJD6
SCHEMBL30281370 0.81 EPHX2 (0.52) EPHX2L3MBTL1MAPTGSK3BJMJD6
SCHEMBL13890753 0.79 KCNK3 (0.48) GSK3BKDM4EDBHGAARECQL
SCHEMBL13890832 0.78 L3MBTL1 (0.68) EPHX2L3MBTL1MAPTPOLBMAPK1
SCHEMBL16689607 0.77 DDR1 (0.44) KDM4EDBHGAARECQLMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090099184-A1 Substituted pyridineamide compounds useful as soluble epoxide hydrolase inhibitors BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2009-04-16 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090099184-A1 Substituted pyridineamide compounds useful as soluble epoxide hydrolase inhibitors EPHX1, EPHX2, NCEH1 EPHX2 2/4885L3MBTL1 4642/4885MAPT 4616/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback